EC Number |
Inhibitors |
Structure |
---|
2.3.1.B41 | 4-phenyl-5-(phenylsulfonyl)-4,5-dihydropyrrolo[1,2-a]quinoxaline |
- |
|
2.3.1.B41 | 5-(phenylsulfonyl)-4-(pyridin-3-yl)-4,5-dihydropyrrolo[1,2-a]quinoxaline |
- |
|
2.3.1.B41 | N,N'-(6-(octadecylamino)-6-oxohexane-1,5-diyl)diacetamide |
- |
|
2.3.1.B41 | N-[(5S)-5-acetamido-6-(dodecylamino)-6-oxohexyl]-N,N-dimethylmethanaminium |
- |
|
2.3.1.B41 | N2-acetyl-N-dodecyl-L-lysinamide |
- |
|
2.3.1.B41 | tert-butyl (5-acetamido-6-(octadecylamino)-6-oxohexyl)carbamate |
- |
|
2.3.1.B41 | tert-butyl (5-amino-6-(dodecylamino)-6-oxohexyl)carbamate |
- |
|
2.3.1.B41 | tert-butyl (5-amino-6-(octadecylamino)-6-oxohexyl)carbamate |
- |
|
2.3.1.B41 | N6-ethanethioyl-N-phenyl-N2-[3-(pyridin-3-yl)propanoyl]-L-lysinamide |
0.2 mM, 18% inhibition, substrate: Ac-RYQ(N6-acetyl)K-7-amido-4-methylcoumarin |
|
2.3.1.B41 | methyl N2-acetyl-N6-ethanethioyl-L-lysyl-L-alaninate |
0.2 mM, 20% inhibition, substrate: Ac-RYQ(N6-acetyl)K-7-amido-4-methylcoumarin |
|